2025-04-08 18:26:30
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Sun Pharmaceutical Industries Ltd reports Rs. 399.84 crore consolidated PAT in Q4 FY20
Posted On : 2020-05-27 15:35:17( TIMEZONE : IST )
SUN PHARMACEUTICAL INDUSTRIES LTD. has reported financial results for the period ended March 31, 2020.
Financial Results (Q4 FY19-20) - QoQ Comparison
The company has reported total income of Rs.8287.17 crores during the period ended March 31, 2020 as compared to Rs.8274.73 crores during the period ended December 31, 2019.
The company has posted net profit / (loss) of Rs.399.84 crores for the period ended March 31, 2020 as against net profit / (loss) of Rs.913.52 crores for the period ended December 31, 2019.
The company has reported EPS of Rs.1.67 for the period ended March 31, 2020 as compared to Rs.3.81 for the period ended December 31, 2019.
| Financials | Q4 FY19-20 | Q3 FY19-20 | % Change |
| Total Income | ₹ 8287.17 crs | ₹ 8274.73 crs |  0.15% |
| Net Profit | ₹ 399.84 crs | ₹ 913.52 crs |  -56.23% |
| EPS | ₹ 1.67 | ₹ 3.81 | -56.17% |
Financial Results (Q4 FY19-20) - YoY Comparison
The company has reported total income of Rs.8287.17 crores during the period ended March 31, 2020 as compared to Rs.7445.45 crores during the period ended March 31, 2019.
The company has posted net profit / (loss) of Rs.399.84 crores for the period ended March 31, 2020 as against net profit / (loss) of Rs.635.88 crores for the period ended March 31, 2019.
The company has reported EPS of Rs.1.67 for the period ended March 31, 2020 as compared to Rs.2.65 for the period ended March 31, 2019.
| Financials | Q4 FY19-20 | Q4 FY18-19 | % Change |
| Total Income | ₹ 8287.17 crs | ₹ 7445.45 crs | 11.31% |
| Net Profit | ₹ 399.84 crs | ₹ 635.88 crs | -37.12% |
| EPS | ₹ 1.67 | ₹ 2.65 | -36.98% |
Financial Results (12 months ended FY 19-20) - YoY Comparison
The company has reported total income of Rs.33473.48 crores during the 12 months period ended March 31, 2020 as compared to Rs.30091.40 crores during the 12 months period ended March 31, 2019.
The company has posted net profit / (loss) of Rs.3764.93 crores for the 12 months period ended March 31, 2020 as against net profit / (loss) of Rs.2665.42 crores for the 12 months period ended March 31, 2019.
The company has reported EPS of Rs.15.69 for the 12 months period ended March 31, 2020 as compared to Rs.11.11 for the 12 months period ended March 31, 2019.
| Financials | Year Ended FY19-20 | Year Ended FY18-19 | % Change |
| Total Income | ₹ 33473.48 crs | ₹ 30091.40 crs | 11.24% |
| Net Profit | ₹ 3764.93 crs | ₹ 2665.42 crs | 41.25% |
| EPS | ₹ 15.69 | ₹11.11 | 41.22% |
Shares of SUN PHARMACEUTICAL INDUSTRIES LTD. was last trading in BSE at Rs.459.05 as compared to the previous close of Rs. 469.2. The total number of shares traded during the day was 249463 in over 6078 trades.
The stock hit an intraday high of Rs. 475.65 and intraday low of 456.75. The net turnover during the day was Rs. 116644468.
